OvAge: an innovative, user-friendly digital methodology that quantifies ovarian reserve by integrating clinical, biochemical and 3D-sonographic data to help decision-making in all phases of woman life

Projektinformationen

Ovage

ID Finanzhilfevereinbarung: 781853

DOI

10.3030/781853

Projekt abgeschlossen

EK-Unterschriftsdatum 31 Juli 2017

Startdatum 1 August 2017

Enddatum 31 Januar 2018

Finanziert unter

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Gesamtkosten

€ 71 429,00

EU-Beitrag

€ 50 000,00

Koordiniert durch

OVAGE SRL
Italy

Periodic Reporting for period 1 - Ovage (OvAge: an innovative, user-friendly digital methodology that quantifies ovarian reserve by integratingclinical, biochemical and 3D-sonographic data to help decision-making in all phases of woman life)

Berichtszeitraum: 2017-08-01 bis 2018-01-31

Zusammenfassung vom Kontext und den Gesamtzielen des Projekts

Infertility is becoming a public health issue in Europe. In the EU, infertility affects approximately 25 million citizens . In worildwide, it is estimated that one out of six people experience some form of infertility during their reproductive lifespan. Europe is characterized by low fertility, postponed childbearing, increase in childlessness among younger generations. OvAge s.r.l. is a business start-up born from one of the best cutting-edge research of the University Magna Graecia of Catanzaro. Its mission is to improve women quality of life by bringing to the international market medical devices for the solution of gynaecological diseases. OvAge s.r.l. is the owner of a pioneering medical device-software able in quantifying women ovarian reserve (OR) by integrating clinical, biochemical and 3D- ultrasonographic data. This instrument, called OvAge®, is already developed as a patented mathematical algorithm. OvAge® combines complementary evaluations to give as a result explicitly the ovarian age of every woman, a ready-to-use information that is going to revolutionize the relationship of women with themselves, their life and with the Specialists in the field of Gynaecology

Arbeit, die ab Beginn des Projekts bis zum Ende des durch den Bericht erfassten Berichtszeitraums geleistet wurde, und die wichtigsten bis dahin erzielten Ergebnisse

Ovage are planning to launch our product in the EU market initially through a web site. After SME instrument phase 1 conclusion, we aim to commercialize it in the rest of the EU market and in the rest of the world. Actually the Ovage's sell strategy contemplates a unique selling point into the web But, this is the best strategy?
The objective of the activities is to identify the best market strategy for Ovage.
The project plan was developed in 4 steps:
1. Recognize the characteristics of the market (Market segment identification)
2. Evaluate best process to keep a client's business (positioning strategy)
3. Define the Ovage’s commercial strategy
4. Investigate possible risks in our commercial strategy

Fortschritte, die über den aktuellen Stand der Technik hinausgehen und voraussichtliche potenzielle Auswirkungen (einschließlich der bis dato erzielten sozioökonomischen Auswirkungen und weiter gefassten gesellschaftlichen Auswirkungen des Projekts)

At the end of the project Ovage knows:
- the right firm positioning
- the product and price strategy to be adopted
- the right price to transfer the rights of the patent

Ovage's logo